ARKG Investment Tracker

Source from:official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·11-15 07:13
      ARKG Investment Tracker position change: Decreased position in Kymera Therapeutics, Inc. by 705 shares, the number of shares held decreased 0.55% compared to the previous period and now represents 0.81% of the total position.
      2.87KComment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·11-15 07:13
      ARKG Investment Tracker position change: Decreased position in Butterfly Network Inc by 29,555 shares, the number of shares held decreased 0.56% compared to the previous period and now represents 1.78% of the total position.
      5.59K4
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·11-15 07:13
      ARKG Investment Tracker position change: Decreased position in COMPASS Pathways plc by 32,865 shares, the number of shares held decreased 0.56% compared to the previous period and now represents 2.71% of the total position.
      2.25KComment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·11-15 07:13
      ARKG Investment Tracker position change: Decreased position in Eli Lilly by 360 shares, the number of shares held decreased 0.56% compared to the previous period and now represents 4.65% of the total position.
      1.28K1
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·11-15 07:13
      ARKG Investment Tracker position change: Decreased position in Beam Therapeutics, Inc. by 17,940 shares, the number of shares held decreased 0.56% compared to the previous period and now represents 3.9% of the total position.
      866Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·11-15 07:13
      ARKG Investment Tracker position change: Decreased position in Generate Biomedicines by 9,465 shares, the number of shares held decreased 0.56% compared to the previous period and now represents 1.08% of the total position.
      6241
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·11-15 07:13
      ARKG Investment Tracker position change: Decreased position in GeneDx Holdings by 3,465 shares, the number of shares held decreased 0.56% compared to the previous period and now represents 1.62% of the total position.
      308Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·11-15 07:13
      ARKG Investment Tracker position change: Decreased position in Nurix Therapeutics by 15,535 shares, the number of shares held decreased 0.56% compared to the previous period and now represents 2.19% of the total position.
      203Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·11-15 07:13
      ARKG Investment Tracker position change: Decreased position in Freenome, Inc. by 10,305 shares, the number of shares held decreased 0.56% compared to the previous period and now represents 0.99% of the total position.
      485Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·11-15 07:13
      ARKG Investment Tracker position change: Decreased position in Ionis Pharmaceuticals by 5,250 shares, the number of shares held decreased 0.56% compared to the previous period and now represents 1.3% of the total position.
      3131
      Report
     
     
     
     

    Most Discussed